1. Deutsche Krebsgesellschaft. Brustkrebs: Definition und Häufigkeit. Abgerufen 19.04.2020, von
https://www.krebsgesellschaft.de/onko-internetportal/basis-informationen-krebs/krebsarten/brustkrebs-definition-und-haeufigkeit.html 2. Robert Koch Institut. Brustkrebs (Mammakarzinom) ICD-10 C50 Zentrum für
Krebsregisterdaten. Abgerufen 19.04.2020, von http://www.krebsdaten.de/Krebs/DE/
Content/Krebsarten/Brustkrebs/brustkrebs_node.html
3. Deutsches Krebsforschungszentrum. Krebsinformationsdienst Risikofaktoren für Brustkrebs. Abgerufen 19.04.2020, von https://www.krebsinformationsdienst.de/
tumorarten/brustkrebs/brustkrebsrisiken-uebersicht.php
4. Iversen L, Sivasubramanian S, Lee AJ, Fielding S, Hannaford PC. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' oral contraception study. Am J Obstet Gynecol. 2017; 216: 580.e1-580.e9.
5. Cao Y, Willets WC, Nimm EB, Stampfer MJ, Giovanucci EL. Light to moderate intake of alcohol, drinking patterns, and risk of cancer: results from two prospective US cohort studies. BMJ. 2015; 351: h4238.
6. Thomson C, Wand D. Hereditärer Brustkrebs. Onkologe. 2012; 18: 216-223 7. Spear SL, Willey SC, Robb GL, Hammond DC, Nahabedian MY. 2006. Surgery of the
Breast. Principles and Art. Kapitel: Incidence, Trends and the Epidemiology of Breast Cancer. 2. Auflage. 2006. Philadelphia: Lippincott Williams and Wilkins: 3-22.
8. Kooperationsgemeinschaft Mammographie. Jahresbericht Evaluation 2017 Deutsches Mammographie Screenings Programm. Abgerufen 20.04.2020, von https://
fachservice.mammo-programm.de/download/downloads/
KOOPMAMMO_Jahresbericht_Eval_2017_20191114_web.pdf
9. Bays JK Physical and mammographic diagnosis of breast cancer and initial work-up.
J Am Med Womens Assoc. 1992; 47:158-160.
10. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, D.K., AWMF).
Interdisziplinäre S3-Leitlinie für die Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Langversion 4.3-Februar 2020:93-96. Abgerufen 1 0 . 0 5 . 2 0 2 0 , v o n h t t p s : / / w w w. a w m f . o r g / u p l o a d s / t x _ s z l e i t l i n i e n 032-045OLl_S3_Mammakarzinom_2020-02.pdf.
11. Gabka CJ, Bohmert H Plastische und Rekonstruktive Chirurgie der Brust. Kapitel:
Sofortrekonstruktion der Brust. 2. Auflage. 2006. München: Georg Thieme Verlag:
252-281.
12. Arbeitsgemeinschaft Gynäkologische Onkologie e.V. Operative Therapie des
Mammakarzinoms unter onkologischen Aspekten. Abgerufen 10.05.2020, von https://www.ago-online.de/fileadmin/ago-online/downloads/_leitlinien/
kommission_mamma/2020/PDF_DE/
2020D%2008_Operative%20Therapie%20des%20Mammakarzinoms%20unter%20onk ologischen%20Aspekten.pdf.
13. Arbeitsgemeinschaft Gynäkologische Onkologie e.V. Prognostische und prädikative Faktoren. Abgerufen 16.06.2020, von https://www.ago-online.de/fileadmin/ago-online/
d o w n l o a d s / _ l e i t l i n i e n / k o m m i s s i o n _ m a m m a / 2 0 2 0 / P D F _ D E / 2020D%2005_Prognostische%20und%20praediktive%20Faktoren.pdf.
14. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg. 2005; 241:629– 639.
15. Smitt MC, Nowels KW, Zdeblick MJ, Jeffrey S, Carlson RW, Stockdale FE, Goffinet DR. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer. 1995; 76: 259–267.
16. Khanna MM, Mark RJ, Silverstein MJ, Julliard G, Lewinsky B, Giuliano AE. Breast conservation management of breast tumors 4 cm or larger. Arch Surg. 1992; 127: 1038–
1041.
17. Veronesi U, Salvador B, Luini A, Greco M, Saccozzi R, del Vecchio M, Mariani L, Zurrida S, Rilke F. Breast conserving is a safe method in patients with small cancer of the breast. Long-term results of three randomized trials on 1973 patients.
Eur J Cancer. 1995; 31: 1574-1579.
18. Fischer B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM.
Reanalysis and results after 12 years follow-up in a randomized clinic trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995; 333:1456-1461.
19. Beadle GF, Silver B, Botnick L, Hellman S, Harris JR. Cosmetic results following
20. Robinson GN, van Heerden JA, Payne WS, Taylor WS, Gaffey TA. The primary surgical treatment of carcinoma of the breast: a changing trend toward modified radical mastectomy. Mayo Clin Proc. 1976; 51: 433–442.
21. Baker RR, Montague AC, Childs JN. A comparison of modified radical mastectomy to radical mastectomy in the treatment of operable breast cancer. Ann Surg. 1979; 189:
553–559.
22. Turner L, Swindell R, Bell WG, Hartley RC, Taster JH, Wilson WW, Alderson MR Leck IM. Radical versus modified radical mastectomy for breast cancer.
Ann R Coll Surg Engl. 1981; 63: 239–243.
23. Maddox WA, Carpenter JT Jr, Laws HL, Song SJ, Cloud G, Frist MM, Balch CM. A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients. Ann Surg. 1983; 198: 207–212.
24. Gerber B, Krause A, Dieterich M, Kundt G, Reimer T. The oncological safety of skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg. 2009; 249: 461-468.
25. Arbeitsgemeinschaft Gynäkologische Onkologie e.V. Onkoplastische und
Rekonstruktive Mammachirurgie. Abgerufen 10.05.2020, von https://www.ago-online.de/fileadmin/ago-online/downloads/_leitlinien/
kommission_mamma/2020/PDF_DE/
2020D%2009_Onkoplastische%20und%20rekonstruktive%20Mammachirurgie.pdf.
26. Apte A, Walsh M, Chandrasekharan S, Chakravorty A. Single-stage immediate breast reconstruction with acellular dermal matrix: experience gained and lessons learnt from patient reported outcome measures. Eur J Surg Oncol. 2016; 42: 39-44.
27. Machleidt A, Schmidt-Feuerherd N, Blohmer JU, Ohlinger R, Kueper J, von Waldenfels G, Dittmer S, Paepke S, Klein S. Reconstructive breast surgery with partially absorbable bi-component SERAGYN® BR soft mesh: an outcome analysis. Arch Gynecol Obstet. 2018; 298: 755-761.
28. Sinnott C, Persing SM, Pronovost M, Hodyl C, McConnell D, Ott Young A.
Impact of postmastectomy radiation therapy in prepectoral versus subpectoral implant-based breast reconstruction. Ann Surg Oncol. 2018; 25: 2899-2908.
29. Casella D, Bernini M, Bencini L, Roselli J, Lacaria MT, Martellucci J, Banfi R, Calabrese C, Orzalesi L. TiLOOP® Bra mesh used for immediate breast reconstruction:
comparison of retropectoral and subcutaneous implant placement in a prospective
single-institution series. Eur J Plast Surg. 2014; 37: 599-604.
30. Paepke S, Ohlinger R, Klein E, Thill M. Präpektorale Implantateinlage in der plastisch-rekonstruktiven Mamachirurgie- ein Diskussionsbeitrag. Senologie. 2018; 15: 115-119.
31. Casella D, Di Taranto G, Marcasciano M, Sordi S, Kothari A, Kovacs T, Lo Torto F, Cigna E, Calabrese C, Ribuffo D. Evaluation of prepectoral implant placement and complete coverage with TiLoop Bra mesh for breast reconstruction: a prospective study on long-term and patient-reported BREAST-Q outcomes. Plast Reconstr Surg. 2019;
143: 1e-9e.
32. Gabka CJ, Bohmert H. Plastische und Rekonstruktive Chirurgie der Brust. Kapitel:
Brustimplantate. 2. Auflage. 2006. München: Georg Thieme Verlag: 252-281.
33. Arbeitsgemeinschaft Gynäkologische Onkologie e.V. Adjuvante Strahlentherapie.
Abgerufen 10.05.2020, von https://www.ago-online.de/fileadmin/ago-online/
downloads/_leitlinien/kommission_mamma/2020/PDF_DE/
2020D%2013%20_Adjuvante%20Strahlentherapie.pdf.
34. Williams JK, Carlson GW, Bostwick J 3rd, Bried JT, Mackay G. The effects of radiation treatment after TRAM flap reconstruction. Plast Reconstr Surg. 1997; 100: 1153-1160.
35. Rogers NE, Allen RJ. Radiation effects on breast reconstruction with the deep inferior epigastric perforator flap. Plast Reconstr Surg. 2002;109:1919-1924.
36. Moyer HR, Pinell-White X, Losken A. The effect of radiation on acellular dermal matrix and capsule formation in breast reconstruction: clinical outcomes and histologic analysis. Plast Reconstr Surg. 2014; 133: 214-221.
37. Hashimi D, Fasih T. Reconstructive breast surgery: compatibility of Strattice™ matrix with radiation therapy. Eur J Surg Oncol. 2016; 42: 216-218.
38. Valdatta L, Cattaneo AG, Pellegatta I, Scamoni S, Minuti A, Cherubino M. Acellular dermal matrices and radiotherapy in breast reconstruction: a systematic review and meta-analysis of the literature. Plast Surg Int. 2014; 2014: 472604.
39. Hille-Betz U, Kniebusch N, Woijcinski S, Henseler H, Heyl V, Ohlinger R, Paepke S, Klapdor R, Krause-Bergmann B. Breast reconstruction and revision surgery for implant-associated breast deformities using porcine acellular dermal matrix: a multicenter study of 156 cases. Ann Surg Oncol. 2015; 22: 1146-1152.
40. Salzberg CA, Ashikari AY, Berry C, Hunsicker LM. Acellular dermal matrix–assisted direct-to-implant breast reconstruction and capsular contracture: a 13-year experience.
Plast Reconstr Surg. 2016; 138: 329-337.
41. Jagsi R, Jiang J, Momoh AO, Alderman A, Giordano SA, Buchholz TA, Kronowitz SJ, Smith BD.Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol. 2014; 32: 919–926.
42. Gabka CJ, Bohmert H. Plastische und Rekonstruktive Chirurgie der Brust. Kapitel:
Sekundäre Brustrekonstruktion. 2. Auflage. 2006. München: Georg Thieme Verlag:
85-99.
43. Alderman AK, Wilkins EG, Kim HM, Lowery JC. Complications in postmastectomy breast reconstruction: two-year results of the Michigan breast reconstruction outcome study. Plast Reconstr Surg. 2002; 109: 2265-2274.
44. Xu H, Wan H, Sandor M, Qi S, Ervin F, Harper JR, Silverman, RP, McQuillan DJ. Host response to human acellular dermal matrix transplantation in a primate model of abdominal wall repair. Tissue Eng Part A. 2008; 14: 2009–2019.
45. Ball JF, Sheena Y, Tarek Saleh DM, Forouhi P, Benyon SL, Irwin MS, Malta CM. A direct comparison of porcine (Strattice™) and bovine (Surgimend™) acellular dermal matrices in implant-based immediate breast reconstruction. J Plast Reconstr Aesthet Surg. 2017; 70: 1076-1082.
46. LifeCell. Produktinformation. Abgerufen 21.11.2019, von http://www.lifecell.com/
health-care-professionals/lifecell- products/stratticetm-reconstructive- tissue-matrix/
47. Nahabedian MY . Acellular dermal matrices in primary breast reconstructions principles, concepts and indications. Plast Reconstr Surg. 2012; 130: 54S-56S.
48. SERAG-WIESSNER. Aufbau und Rekonstruktion - unterstützend und individuell SERAGYN® BR. Netzgestützter Wiederaufbau der weiblichen Brust. Abgerufen 13.03.2020, von https://www.serag-wiessner.de/fileadmin/redakteur/PDF/
textile_implantate/851120-2013_09-de_SERAGYN.pdf.
49. Firma pfm medical ag, Köln, Deutschland. Quality and Experience TiLOOP Bra.
Abgerufen 13.03.2020, von https://www.pfmmedical.com/de/produktkatalog/
netzimplantate_brustchirurgie/tiloopR_bra/index.html .
50. Firma pfm medical ag, Köln, Deutschland. Titanisierte Netzimplantate für die
Brustchirurgie TiLOOP® Bra, TiLOOP® Bra MPX. Informationsmaterial. 10.05.2020
51. Lin KY, Blechman AB, Brenin DR. Implant-based, two-stage breast reconstruction in the setting of radiation injury: an outcome study. Plast Reconstr Surg. 2012; 129: 817–
823.
52. Zielinski C, Jakesz R. Onkologie heute. Mammakarzinom. Kapitel: Strahlentherapie des Mammakarzinoms von Resch A. 2. Auflage. 1999. Wien, New York. Springer-Verlag:
52-53.
53. Scherer E, Sack H. Strahlentherapie. Radiologische Onkologie. 4.Auflage. 1996. Berlin, Heidelberg. Springer-Verlag: 677-678.
54. Blohmer JU. Operative Therapie des Mammakarzinoms. Onkologe. 2015; 21: 220-230.
55. LifeCell. Kommerzielle Bezeichnung: Strattice Rekonstruktion Gewebematrix. FSCA-Kennung: EVAL-2015-002.Art der Maßnahme: Sicherheitshinweis : 23. Juni 2015.
A b g e r u f e n 1 0 . 0 5 . 2 0 2 0 , v o n h t t p s : / / w w w. a e k o o e . a t / i n d e x . p h p ? eID=dumpFile&t=f&f=619&token=1b26ca4df8988f71621d251f7a50cfab48b11ac4.
56. pfm medical, Köln, Deutschland. Quality and Experience; Titanized Mesh Implants TiLOOP Bra. Instruction for Use. 2016. Abgerufen 10.05.2020, von https://
www.pfmmedical.com/productcatalogue/mesh_implants_breast_surgery/tiloopr_bra/
index.html.
57. SERAG-WIESSNER. Gebrauchsanweisung SERAGYN. Abgerufen 10.05.2020, von https://ifu.serag-wiessner.de/fileadmin/ifu/CE0900/CE090016.pdf.
58. Loo YL, Kamalathevan P, Ooi PS, Mosahebi A. Comparing the outcome of different biologically derived acellular dermal matrices in implant-based breast reconstruction: a meta-analysis of the literatures. Plast Reconstr Surg Glob Open. 2018; 6: e1701.
59. Hillberg NS, Ferdinands PI, Dikmans REG, Winkens B, Hommes J, van der Hulst RRWJ. Is single-stage implant-based breast reconstruction (SSBR) with an acellular
matrix safe? Eur J Plast Surg. 2018; 41: 429-438 60. Dieterich M, Paepke S, Zwiefel K, Dieterich H, Blohmer J, Faridi A, Klein E, Gerber B,
Nestle-Kraemling C. Implant-based breast reconstruction using a titanium-coated polypropylene mesh (TiLOOP Bra): a muticenter study of 231 cases. Plast Reconstr Surg. 2013; 132: 8e-19e.
61. Eichler C, Schulz C, Tangarajah F, Malter W, Warm M, Brunnert K. A retrospective head-to-head comparison between TiLoop Bra/TiMesh® and Seragyn® in 320 cases of
62. Dikmanns, RE, Negenborn, VL, Bouman, MB, Winters HA, Twisk, JW, Ruhé PQ, Mureau, MA, Smit, JM, Tuinder S, Eltahir Y, Posch NA, van Steveninck-Barends JM, Meisters-Caberg MA, van der Hulst RR, Ritt MJ, Mullender MG. Two-stage implant-based breast reconstruction compared with immediate one-stage implant-implant-based breast reconstruction augmented with an acellular dermal matrix: an open-label, phase 4, multicentre, randomised, controlled trial. Lancet Oncol. 2017; 18: 251-258.
63. Glasberg SB, Light D. AlloDerm and Strattice in breast reconstruction: a comparison and techniques for optimizing outcomes. Plast Reconstr Surg. 2012; 129: 1223-1233.
64. Salzberg CA, Dunavant C, Nocera N. Immediate breast reconstruction using porcine acellular dermis (Strattice): long-term outcomes and complications. J Plast Reconstr Aesthet Surg. 2013; 66: 323-328.
65. Colwell AS, Damjanovic B, Zahedi B, Medford-Davis L, Hertl C, Austen WG Jr.
Retrospective review of 331 consecutive immediate single-stage implant reconstructions with acellular dermal matrix. Plast Reconstr Surg. 2011; 128:
1170-1178.
66. Craig ES, Clemens MW, Koshy JC, Wren J, Hong Z, Butler CE, Garvey CE, Selber JC, Kronowitz SJ. Outcomes of acellular matrix for immediate tissue expander reconstruction with radiotherapy: a retrospective cohort study. Aesthet Surg J. 2019; 39:
279-288.
67. Himsl I, Drinovac V, Leonhard M, Stöckl D, Weissenbacher T, Dian D. The use of porcine acellular dermal matrix in silicone implant-based breast reconstruction. Arch Gynecol Obstet. 2012; 286: 187-192.
68. Yang JY, Kim CW, Lee JW, Kim SK, Lee SA, Hwang E. Considerations for patient selection: prepectoral versus subpectoral implant-based breast reconstruction. Arch Plast Surg. 2019; 46: 550–557.
69. Lohmander F, Lagergren J, Roy PG, Johansson H, Brandberg Y, Eriksen C, Frisell J.
Implant based breast reconstruction with acellular dermal matrix: safety data from an open-label, multicenter, randomized, controlled trial in the setting of breast cancer treatment. Ann Surg. 2019; 269: 836-841.
70. Dieterich M, Reimer T, Dieterich H, Stubert J, Gerber B. A short-term follow-up of implant based breast reconstruction using a titanium-coated polypropylene mesh (TiLOOP Bra). Eur J Surg Oncol. 2012; 38: 1225-1230.
71. Chen WX, Cheng L, Xu LY, Zhou YL. A short follow-up of prosthesis-based breast reconstruction using TiLOOP
®
Bra surgical mesh. Niger J Clin Pract. 2019; 22:1115-1119.
72. Ng CE, Pieri A, Fasih T. Porcine acellular dermis-based breast reconstruction:
complications and outcomes following adjuvant radiotherapy. Eur J Plast Surg. 2015;
38: 459-462.
73. Potter S, Conroy EJ, Cutters RI, Williamson PR, Whisker L, Trush S, Skillman J, Barnes NLP, Mylvaganam S, Teasdale E, Jain A, Gardiner MD, Blazeby JM, Holcombe C, iBRA Steering Group; Breast Reconstruction Research Collaborative
Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study Lancet Oncol. 2019; 20: 254-266.
74. Sbitany H., Gomez-Sanchez C, Piper M, Lentz R. Prepectoral breast reconstruction in the setting of postmastectomy radiation therapy: an assessment of clinical outcomes and benefits. Plast Reconstr Surg. 2019; 143: 10-20.
75. Dikmans RE, El Morabit F, Ottenhof MJ, Tuinder SM, Twisk JW, Moues C, Bouman MB, Mullender MG. Single-stage breast reconstruction using Strattice: a retrospective study. J Plast Reconstr Aesthet Surg. 2016; 69: 227-233.
76. Yao X, Guo Y, Tu Y, Yao F, Chen C, Sun S, Zhang X. Simple prosthesis versus prosthesis plus titanium-coated polypropylene mesh for implant-based immediate breast reconstruction after total mastectomy for breast cancer. Gland Surg. 2019; 8: 773–783.
77. Loo YL and Haider S. The use of porcine acellular dermal matrix in single-stage, implant-based immediate breast reconstruction: a 2-center retrospective outcome study.
Plast Reconstr Surg Glob Open. 2018; 6: e1895.
78. Soboti N, Weitzmann RE, Nealon KP, Jimenez RB, Gfrerer L, Mattos D, Ehrlichman RJ, Gadd M, Specht M, Austen WG, Liao EC. Evaluation of capsular contracture following immediate prepectoral versus subpectoral direct-to-implant breast reconstruction. Sci Rep. 2020; 10: 1137.
79. Gschwantler-Kaulich D, Schrenk P, Bjelic-Radisic V, Unterrieder K, Leser C, Fink-Retter A, Salama M, Singer C. Mesh versus acellular dermal matrix in immediate implant based breast reconstruction- a prospective randomized trial. Eur J Surg Oncol.
80. Lin K, Johns FR, Gibson J, Long M, Drake DB, Moore MM. An outcome study of breast reconstruction: persurgical identification of risk factors for complications. Ann Surg Oncol. 2001; 8: 586-591.
81. Paepke S. Abschlussbericht. Einsatz des teilresorbierbaren Zweikomponenten-Polypropylen-Vicryl-Meshs (SEARGYN®BR) als Gewebeinterponat in der plastisch- rekonstruktiven Mammachirurgie- Erste Erfahrungen. Senologie. 2012; 9: 217-222.
82. Mitchell RE. Porcine acellular dermis-assisted breast reconstruction: influence of adjuvant radiotherapy on complications and outcomes. Plast Reconstr Surg Glob Open.
2013; 1: e77.
83. Hughes K, Neoh D. Neoadjuvant radiotherapy: changing the treatment sequence to allow immediate free autologous breast reconstruction. J Reconst Mikrosurg. 2018; 34:
624-631.
84. Berbers J, van Baardwijk A, Houben R, Heuts E, Smidt M, Keymeulen K, Bessems M, Tuinder S, Boersma LJ. Reconstruction: before or after postmastecomy radiotherapy? A systematic review of the literature. Eur J Cancer. 2014; 50: 2752-2762.
85. Cheng G, Zhang Y, Xue J, Liu C, Sun L, Gu X, Zhang H, Liu C.
Surgical outcomes of implant-based breast reconstruction using TiLoop Bra mesh combined with pectoralis major disconnection. Ann Plast Surg. 2019; 83: 396-400.
86. Yao X, Guo Y, Tu Y, Yao F, Chen C, Sun S, Zhang X. Simple prosthesis versus prosthesis plus titanium-coated polypropylene mesh for implant-based immediate breast reconstruction after total mastectomy for breast cancer. Gland Surg. 2019; 8: 773-783.
87. Thill M, Faridi A, Meiré A, Gerber-Schäfer C, Baumann K, Blohmer JU, Mau C, Tofall S, Nolte E, Strittmatter HJ, Ohlinger R, Paepke S. Patient reported outcome and cosmetic evaluation following implant-based breast-reconstruction with a titanized polypropylene mesh (TiLOOP® Bra): a prospective clinical study in 269 patients.
Eur J Surg Oncol. 2020; 46: 1484-1490.
88. Tang R, Coopey SB, Colwell AS, Specht MC, Gadd MA, Kansal K, McEvoy MP, Merrill AL, Rai U, Taghian A, Austen WG, Smith BL. Nipple-sparing mastectomy in irradiated breasts: selecting patients to minimize complications. Ann Surg Oncol. 2015;
22: 3331-3337.